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The capacity of ultraviolet B (UVB) radiation to ci�m­
age the cutaneous immune system has been extensively 
documented, and there is good reason to believe that 
UVB-induced damage is a critical, albeit permissive, 
factor in the development of sunlight-induced skin 
cancen. A summary of the evidence shows that acute, 
low-dose UVB protocols, which resemble quantita­
tively and qualitatively the manner in which human 
beings typically experience sun exposure, alter the cu­
taneous immnne system in at least two important 
ways: they impair the induction of contact hypersensi­
tivity to cutaneous antigens, and induce antigen-spe­
cific tolerance. In mice there is compelling evidence 
that immunogenetic factors dictate whether UVB ra­
diation will impair contact hypersensitivity induction 
or not. The genetic loci that contain the relevant poly­
morphic alleles include tumor necrosis factor-a and 
lipopolysaccharide. Because the effects ofUVB radia­
tion on contact hypersensitivity induction are mim­
icked by intracutaneous injections of subinflammatory 
doses of tumor necrosis factor-a or cis-urocamc acid, 
the favored hypothesis to explain the mechanism of 
action ofUVB radiation in UVB-susceptible individu­
als is that UVB-dependent transformation of trans- to 
cis-urocanic acid in the epidermis triggen the intracu-
CONCERNING THE RELATIONSHIPS AMONG UVB 
RADIATION, DAMAGE TO THE IMMUNE SYSTEM, 
AND SKIN CANCER 
There is compelling evidence that intense and/or prolonged sun 
exposure is the most important environmental factOr in the patho­
genesis of skin cancer [1,2]. Individuals living in geographic regions 
of the world with the greatest amount (intensity, duration) of inci­
dental sunlight have the highest rates of skin cancer, and the distri­
bution of malignant lesions is primarily on sun-exposed areas [3]. 
The incidence of skin cancer is far lower in populations with deeply 
pigmented skin, indicating that melanin deposits offer significant 
protection against the disease. Among Caucasians with comparable 
Skin hue and color and who live in a region of high skin exposure, 
not all individuals suffer similar degrees of cutaneous sun damage, 
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taneous release of excess amounts of tumor necrosis 
factor-a. By transiently immobUizing Langerhans 
cells and other local antigen-presenting cells within 
the skin, the requirement that hapten be brought to the 
draining lymph node to sensitive naive hapten-specific 
T cells is not met, and contact hypenensitivity fails to 
develop. Because the UVB-susceptibility and UVB-re­
sistance traits have also been demonstrated in human 
beings, the hypothesis is advanced that these traits are 
similarly under control of immunogenetic factors, and 
that a constellation of immune susceptibility genes 
contributes to the risk of developing sunlight-induced 
skin cancer. The cellular and molecular basis ofUVB­
induced tolerance is not as well described, but current 
evidence suggests that different mechanisms, and pre­
sumably different polymorphic genes, dictate whether 
tolerance will emerge after UVB exposure in mice. 
Because acute, low-dose UVB also induces tolerance in 
human beings, the immunogenetic factors that dictate 
tolerance of this type may also contribute to the risk of 
developing sunlight-induced skin cancer. Kq wo"': 
contact hJPel"Smsitif1i'1/tolerdflU/skin Cdncer /tutrUJr neerom 
fddor-alpha/immunogenetics.] Invest DermatoI10J:107S-
111S,1994 
nor does skin cancer develop in all similarly exposed individuals. 
Data of this type suggest that host genetic factors, in addition to the 
genes that dictate melanin deposition in the skin, may play a role in 
swceptibility to sunlight-induced skin cancer. 
Epidemiologic evidence in human beings strongly implicates 
electromagnetic energy in the ultraviolet B (UVB) spectrum of 
sunlight as the oncogenic agent [4,5]. Moreover, experimental evi­
dence indicates that bombardment of DNA within epidermal cells 
with UVB radiation produces mutations that lead eventually to the 
malignant phenotype [6,7]. In fact, stereotypic mutations caused by 
DNA have been found in tumor-suppressor genes (as well as other 
genes) within cutaneow squamow cell cancers [8]. In addition to 
the capacity of UVB radiation to induce cancer-promoting muta­
tions, this component of the solar energy spectrum has also been 
linked to damage to the immune system [9,10]. Itis widely believed 
that surveillance of somatic tissues for malignantly transformed 
cells is an important function of the immune system. Therefore, the 
capacity of UVB radiation to damage the immune system as it is 
induced through, and expressed in, the skin may be an important 
contributor to skin cancer development. 
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Experimental demonstration of the validity of the concept that 
UVB radiation induces skin cancer in part by damaging the immune 
system was first reported by Kripke [11] and Daynes et al [12]. These 
investigators chronically exposed laboratory mice to high doses of 
UVB radiation. After prolonged exposure the animals developed 
skin cancers, and displayed several immune-system aberrations. 
Survey of the lymphoid organs of chronically UVB-treated mice 
has revealed a profound deficit in professional antigen-presenting 
cells (APC) in the spleen [13]. In addition, the spleens contain regu­
latory T cells that suppress the ability of normal mice to reject 
UVB-induced, syngeneic tumors [14]. These aberrations actually 
precede the emergence of cutaneous neoplasms. In addition, UVB­
exposed mice of this type are unable to reject UVB-induced skin 
tumors from syngeneic tumor bearers, and the mice are unable to 
develop contact hypersensitivity (CH) when hapten is painted on 
skin (exposed or unexposed). Whereas this list of immunologic 
abnormalities is extensive, mice exposed to chronic UVB irradia­
tion do not have a global immune deficiency. For example, they 
readily form circulating antibodies when immunized with a wide 
variety of antigens, and they can apparently reject allogeneic skin 
grafts in normal fashion. According to Kripke, all strains of mice are 
equally susceptible to the chronic, high-dose UVB regimen, imply­
ing that acquisition of immune abnormalities and development of 
skin cancer in this artificial circumstance is not under the control of 
polymorphic genetic loci. 
More recently, Kripke and colleagues [9], as well as Noonan et al 
[13] have used a single, large dose ofUVB radiation to cripple the 
systemic immune apparatus of mice. Whereas this regimen has not 
been demonstrated to produce skin cancers, it has been found to 
produce a systemic immune defect in which the ability of mice to 
acquire and display CH to epicutaneously applied haptens is se­
verely impaired. In this model system, the initial exposure to hapten 
is delayed 48 - 72 h after UVB exposure, and the hapten is not 
necessatily applied to the UVB-exposed site. Therefore, both 
chronic and acute high-dose models of UVB-induced immune de­
fects appear to act systemically, rather than locally, for example, at 
the site of UVB exposure. 
By contrast, Bergstresser andStreilein developed an acute, low­
dose UVB exposure protocol in the early 1980s that appears to have 
a prominent local effect at the irradiated site [15]. In this model, 
shaved abdominal mouse skin is exposed on four consecutive days to 
UVB radiation (400 ] j m2). Shortly after the last exposure, hapten is 
applied to the irradiated site. In appropriate strains of mice (see 
below), CH falls to develop [16]. However, ifhapten is applied to an 
unirradiated skin site shortly after the completion of the fourth 
UVB exposure, vigorous CH is induced. Therefore, this acute, low­
dose UVB protocol reveals that there is a strictly local effect ofUVB 
radiation that impairs the induction of contact hypersensitivity, but 
only if the hapten is applied to the irradiated site. Whereas this 
outcome differs from the high-dose UVB models described above, 
there are other features of the immune effects of an acute low-dose 
regimen that are similar. For example, mice that first experience 
hapten through UVB-irradiated skin are rendered specifically unre­
sponsive, that is, they are unable to acquire hapten-specific CH 
when treated subsequently with an immunogenic regimen of hap­
ten. Moreover, the spleens of these mice contain hapten-specific 
suppressor cells that can adoptively transfer unresponsiveness to 
naive, syngeneic mice. Perhaps the most interesting features of the 
response of mice to the acute, low-dose UVB regimen is that the 
ability to develop CH to hapten painted on UVB-exposed skin is 
genetically controlled [16]. 
IMMUNOGENETIC FACTORS THAT GOVERN 
DELETERIOUS EFFECTS OF UVB RADIATION ON 
CONTACT HYPERSENSITIVITY INDUCTION IN MICE 
The acute low-dose UVB experiments described earlier were origi­
nally conducted in C57BLj6 mice. When similar experiments were 
carried out in BALB/c mice, a different answer was obtained 
[16,17]. Dinitrofluorobenzene (DNFB) painted on UVB-exposed 
skin of BALBjc mice induced intense CH, unlike in C57BLj6. 
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Figure 1. Effect ofUVB on induction of contact hypersensitivity. 
Groups of normal human subjects (Control), patients with basal and squa­
mous cell skin cancer (Skin Ca), and patients with malignant melanoma 
(Malig Melan) received four exposures ofUVB radiation (144 mJJcm2 ) to 
buttock skin followed by DNCB (2000 p,g) applied to the same site. The 
intensity of challenge reactions elicited on forearm skin 30 d later with 
DNCB (50 Jlg) are presented. 
This observation led to a survey of inbred mouse strains to deter­
mine whether there are strain-dependent differences in the ability 
of UVB radiation to impair induction of CH (UVB-susceptible 
[UVB-S]), or to fail to impair CH induction (UVB-resistant [UVB­
R]).Presently, 33 different genetically defined strains of mice have 
been subjected to this analysis [17,18]. Of these mice, 13 strains 
proved to be UVB-S, whereas the remainder (20) proved to be 
UVB-R. Fl hybrids derived from UVB-S and UVB-R strains tested 
as UVB-S, which means that the UVB-S trait is dominant. Included 
in this survey were two strains of C3H mice (HeN, He]) and 
C57BLjl0 mice (BI0, BI0.ScN) . C3H/He] and B10.ScN mice 
have mutations at the Lps locus that interfere with their ability to 
respond to bacterial lipopolysaccharide (LPS) . HeN, C57BLjl0, 
and all other strains of mice respond normally to LPS. In our study, 
C3H/He] and B10.ScN mice tested as UVB-R, whereas C3H/ 
HeN and C57BLjl0 tested as UVB-S. This result indicates that the 
Lps locus is involved in the regulation of the effects of UVB on 
cutaneous immunity. With the aid of H-2 congenic mice, it was 
determined that a second genetic locus that governs the effects of 
UVB radiation on cutaneous immunity is located within H-2. The 
results of the 33 strains of mice tested for UVB-S and UVB-R are 
prese�ted in Fig 1, according to their H-2 haplotype. It is ap­
parent that only mice possessing a portion of the H-2d chromosome 
display the UVB-R trait. Because mice of the H-2" haplotype 
are also UVB-R, and only the portion ofH-2 telomeric to H-2E is 
derived from the H-2d haplotype, the locus dictating the UVB-S 
and UVB-R traits must also reside telomeric to H-2E [18]. 
The chromosomal region ofH-2 fromE to D contains numerous 
loci that do not encode transplantation antigens. This region 
(termed class III) contains loci that encode several components of 
the serum complement system, heat shock proteins, and several 
tumor necrosis factors (TNF) . Because TNFer is a major mediator of 
th,e LPS effect, we sought evidence of polymorphism at Tnfer locus 
,inUVB-S and UVB-R strains of mice. A restriction enzyme site 
(BamHI) exists in the murine Tnfer locus [19]. When DNA from 
numerous UVB-S and UVB-R strains was analyzed for this restric­
tion fragment length polymorphism (RFLP), a Tnfer-related 10.5-
kb fragment was always detected among UVB-R mice, whereas a 
12.0-kb fragment was always detected among UVB-S mice. There­
fore, a polymorphism exists at the murine Tnfer locus and the two 
alleles at this locus correlate perfectly with the UVB-dependent 
phenotypes, strongly implicating Tnfa as the intra-major histo­
compatibility complex locus that contributes to these disparate phe­
notypes. 
We have cloned and sequenced eight different murine Tnfa al­
leles, including both the 5' and 3' untranslated ( UT ) regions. Dif-
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ferences of interest to the UVB-dependent J?henotypes were limited 
to the first intron and to the 5' UT region l18]. The BamH I site of 
Tnfotl is present at position 329 of the first intron, and is represented 
by a single base change. In addition, the Tnfotl allele possesses a 
unique microsatellite of (CAh4 immediately 5' of the first cytokine 
response element. Actually, all Tnfa alleles have a microsatellite at 
this site, but no other allele has precisely 14 (CA) repeats. We 
suspect, but have no direct evidence, that it is this region of the Tnfa 
locus that dictates the phenotypes of UVB-R and UVB-S. Microsa­
tellites in regulatory regions such as this can have a dramatic effect 
on transcriptional efficiency of genes [20]. As summarized below, 
this suspicion is also related to functional evidence implicating ex­
cess TNFa production in development of the UVB-S trait. ' 
To summarize, acute, low-dose UVB radiation reveals two phe­
notypic traits in mice: UVB-S and UVB-R. The UVB-S trait is 
dominant, whereas UVB-R is recessive. These phenotypes are ge­
netically determined by polymorphic alleles at two independent 
genetic loci: Lps and Tnfa. The UVB-R phenotype is dictated when 
homozygosity for resistance exists at either the Lps or the TnIa 
locus. The resistance alleles are Lpsd and Tnfotl. Because both loci are 
involved in transcriptional and translational control of TN Fa pro­
duction, the phenotypes of UVB-S and UVB-R may represent 
quantitatively different TNFa responses within the epidermis to 
acute, low dose UVB exposure. 
CELLULAR AND MOLECULAR MECHANISMS 
RESPONSmLE FOR IMPAIRED CONTACT 
HYPERSENSITIVITY INDUCTION AFTER UVB 
RADIATION IN MICE 
Considerable progress has been made in understanding the cellular 
and molecular mechanisms that are involved when UVB radiation 
impairs CH induction in mice. As already described, UVB radiation 
only impairs CH induction in genetically susceptible mice, and the 
genetic evidence strongly implicates the pleiotropic cytokine, 
TNFa. To summarize a long series of studies [17], it has been 
demonstrated that intracutaneous (Ie) i�ection of sub-inflamma­
tory amounts of murine recombinant TNFa into UVB-S mice re­
creates the UVB-dependent phenotype . That is, when DNFB is 
painted epicutaneously on a site ofUVB-S mice into which TFNa 
was injected 2 h previously. CH fails to develop. If enough TNFa is 
injected IC into UVB-R mice, CH induction is similarly impaired. 
This outcome emphasizes that the difference between UVB-S and 
UVB-R mice is quantitative, rather than qualitative. 
More important, when hapten is painted on UVB-exposed skin 
of UVB-S mice that have been treated with neutralizing anti-TNFa 
antibodies, CH develops normally. This result confirms thatTNFa 
is the critical mediator of the effect of UVB on impaired CH induc­
tion in UVB-S mice. Insight into the mechanism of action of TN Fa 
in this setting comes from studies of the effects ofUVB and TNFa 
on epidermal Langerhans cells [21]. Intracutaneous i�ection of 
TNFa leads within 5-10 min to dramatic changes in Langerhans 
cells in the overlying epidermis: the cells lose their dendritic pro­
cesses, and their cell bodies become swollen. A similar effect on 
Langerhans cells occurs in epidermis after a single exposure to UVB, 
although it takes a little longer to be observed microscopically . The 
dose of IC-injected TNFa necessary to alter Langerhans cell mor­
phology in UVB-S mice is considerably less than that required to 
cause similar changes in epidermal cells of UVB-R mice. Interest­
ingly, the morphologic changes in Langerhans cells caused by a 
single exposure to UVB radiation is completely reversed by anti­
TNFa antibodies. These findings point to Langerhans cells as the 
target of the UVB-induced TNFa effects that lead to impaired CH 
induction in UVB-S mice. Circumstantial evidence suggests that 
Langerhans cells or other APC exposed to TNFa undergo cytoskel­
etal changes which transiently impair the cells' ability to migrate. It 
is known that induction of CH requires cutaneous antigen-present­
ing cells to bring the hapten to the draining lymph node for presen­
tation to naive T cells. Therefore, we speculate that the ability of 
TNFa (directly), and UVB radiation in UVB-S mice (indirectly), to 
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impair CH induction is predicated on the capacity of TNFa to 
immobilize cutaneous APC when hapten is applied to treated skin. 
It is important to point out that IC injection of cis-urocanic acid 
(UCA) also alters Langerhans cell morphology, and impairs the 
induction of CH if hapten is painted on the i�ected site [22]. De­
Fabo and Noonan [23] have provided evidence that trans-UCA is a 
photoreceptor for UVB radiation in the skin, and they and others 
have re�orted that cis-UCA is a potent systemic immunosuppres­
sant [24J. Therefore, our observation that IC-injected cis-UCA in­
terferes with CH induction (in a strictly local, rather than systemic 
fashion) implicates this interesting molecule that is present in high 
concentration in the upper layers of the epidermis. Because neutral­
izing anti-TNFa antibodies reverse the effects of cis-UCA on Lan­
gerhans cell morphology and on impaired CH induction, we fur­
ther speculate that the sequence leading from UVB radiation to 
impaired CH induction in UVB-S mice goes as follows: a) UVB 
racemizes trans-UCA to the cis isoform; b) cis-UCA leads to tran­
scriptional activation of the TnIa genes; c) cis-UCA, through an 
LPS-like effect, causes stabilization of the mRNA for TNFa; d) this 
results in excess production of TN Fa that acts on local APC, tran­
siently preventing them from emigrating from the skin. As a conse­
quence, the time-restricted opportunity to sensitize haptenspecific 
T cells in the draining lymph node is lost, and CH induction fails. 
DELETERIOUS EFFECTS OF UVB RADIATION 
ON CONTACT HYPERSENSITIVITY INDUCTION 
IN HUMANS 
Indications from experiments in mice that the effects of UVB on 
CH induction is genetically determined suggested the possibility 
that the same may be true in humans. Moreover, if human beings 
should prove to be polymorphic for the effects of UVB on CH 
induction, this phenomenon might be related to susceptibility to 
skin cancer and other cutaneous diseases caused by exposure to sun­
light. Therefore, a protocol has been devised to evaluate human 
beings for the phenotypes ofUVB-S and UVB-R [25,26]. A univer­
sally sensitizing dose of dinitrochlorobenzene (DNCB) was painted 
on buttock skin surfaces that had received four daily exposures to 
acute UVB radiation (144 mJ/cm2). When these individuals were 
tested on the forearm 30 d later with dilute DNCB, approximately 
40% failed to respond, that is, they wereUVB-S. This definition is 
relevant because the remaining individuals responded to forearm 
challenge with vigorous CH responses, equivalent to unirradiated, 
positive controls. These results indicate that the phenotypes of 
UVB-S and UVB-R exist in humans. A similar conclusion was 
reached more recently by Cooper et al [27], although that study had 
important differences in methodology of sensitization and chal­
lenge from the protocols we have employed. 
Insight into the potential biologic meaning of the UVB-S and 
UVB-R traits in humans was given by results of similar experiments 
conducted in a large number of individuals with biopsy-proved basal 
and/or squamous cell skin cancer (but who were disease free at the 
time of the study). As revealed in Fig 1, only three of 41 patients 
developed CH when DNCB was first placed on UVB-irradiated 
buttock skin. Another group of patients with malignant melanoma, 
but without evidence of local or systemic disease at the time of 
study, was also entered into the UVB treatment protocol. Eleven 
patients have completed the study to date, and all proved to be 
UVB-S. Therefore, the phenotype of UVB-S, as we define it, is a 
characteristic of virtually all patients with skin cancer, and there­
fore, this trait may be considered a risk factor for skin cancer. 
EVIDENCE CONCERNING A GENETIC BASIS FOR 
UVB-SUSCEPTmILITY AND RESISTANCE IN HUMANS 
Because the UVB-S and UVB-R traits are genetically determined in 
mice, and because the phenotypic traits ofUVB-S and UVB-R exist 
in human beings, it is important to know whether genetic factors 
also dictate these traits in man. Two approaches have been taken to 
resolving this issue. The first is a concordance study in which indi­
viduals that were designated as UVB-S and UVB-R on the basis of 
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testing with DNCB were retested with the non-cross-reactive 
hapten, diphencyprone (DPCP) . The rationale for this experiment 
is that the phenotypes ofUVB-S and UVB-Rshould be stable in any 
given individual, and should be independent of the hapten, that is, if 
the phenotypic traits ofUVB-S and UVB-R ate genetically deter­
mined, an individual that is UVB-S with respect to hapten A 
(DNCB) should also be UVB-S with respect to hapten B (DPCP) . 
Forty-three individuals (50% of whom were UVB-S when tested 
with DNCB) were selected as volunteers.· Of these volunteers, six 
had a history of skin cancer and the remainder were healthy con­
trols. These individuals were subjected again to the acute,low-dose 
UVB protocol, but with DPCP as the hapten. Of the healthy con­
trols, 40% proved to be UVB-S with DPCP, and all of the skin­
cancer patients displayed this phenotype. When the results with 
DNCB and DPDP were compared for each subject, the rate of 
concordance was 79%. Therefore, the vast majority of individuals 
that ate designated as UVB-S with one hapten (DNCB) ate also 
designated as UVB-S with an unrelated hapten (DPCP). This evi­
dence provides circumstantial evidence that the trait we define as 
UVB-S in humans is genetically determined. 
The second approach we have taken to prove or disprove the 
genetic hypothesis is a moleculat biologic one. Because polymor­
phism exists at the TnJa locus in mice, and this polymorphism 
predicts the UVB-dependent phenotypes of different strains of 
mice, we have attempted to determine a) whether polymorphisms 
exist at the human Tnfa locus, and b) if the alleles correspond to 
UVB-S and UVB-R phenotypes. The human Tnfa locus resides 
within the HLA complex in a similar orientation to that described in 
mice. At the time this study was initiated, no RFLP was known to 
discriminate among possible TnJa alleles, even though more than 
20 restriction enzymes had been examined [28]. Accordingly, we 
obtained genomic DNA from subjects we had designated as UVB-S 
and UVB-R and proceeded to clone and sequence their respective 
Tn/a genes. One human Tnfa gene had already been cloned and 
sequenced and was in the literature to serve as a reference point. 
Among 6 Tnfa genes cloned from three UVB-S and three UVB-R 
individuals, sequences were obtained for the entire coding region 
(including introns), and for both the 5' and 3' untranslated regions. 
Although single base changes were detected in the coding region in 
one or another individual, no single position proved informative 
with respect to the UVB-dependent phenotypes. Unfortunately, no 
stereotypic microsatellite exists within the 5' UT of the human 
Tnfa locus. However, a single set of base changes was detected at 
position 1037, which is 5' of the transcriptional start site. The Tnfa 
genes of three UVB-R individuals, as well as the published se­
quence, contain a C at this site, whereas the TnJa genes from three 
UVB-S individuals possess a T at this site. The preliminary evidence 
gives hope that a polymorphic site within the human TnJa locus has 
been identified. Only with considerably more work will we know 
whether alleles at this site correlate with the UVB-dependent phe­
notypes. Therefore, preliminary and incomplete evidence has been 
gathered to test the possibility that the UVB-S and UVB-R traits are 
genetically determined in humans and that evidence supports the 
hypothesis, although it is far from proved. 
TOLERANCE INDUCTION IN MICE FOLLOWING 
HAPTEN APPLICATION TO UVB-IRRADIATED SKIN 
Hapten-specific unresponsiveness is also a characteristic of UVB-S 
mice that first encounter hapten via UVB-exposed skin [15]. And as 
mentioned previously, tolerance of this type is correlated with the 
presence of T suppressor cells in the lymphoid organs of treated . 
mice [291. However, similar suppressor cells have also been identi­
fied in the spleens of UVB-R mice that were exposed to acute, 
low-dose UVB followed by hapten application to the irradiated site 
[30]. This evidence implies that the ability of UVB radiation to 
• Golomb C, Tie C, Kurimoto I, Taylor JR, streilein JW: Functional 
evidence tha the UVB-S and UVB-R phenotypic traits are genetically deter­
mined (abstr).] Invest Dermato/100:601, 1993. 
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impair CH induction, and the ability of this treatment to induce 
hapten-specific tolerance, may be mediated by different mecha­
nisms. If that should be the case, then the possibility exists that the 
immunogenetic factors that influence tolerance induction may be 
different from the genetic factors that have been implicated in the 
pathogenesis of impaired CH induction. 
We have recently completed experiments to determine whether 
TNFa and cis-UCA can promote tolerance induction. t To summa­
rize the results of these experiments, it has been found that IC 
injection of either murine recombinant TNFa or cis-UCA into 
both UVB-S and UVB-R mice, followed by epicutaneous applica­
tion of DNFB to the injected site, results in profound and hapten­
specific tolerance. Moreover, the spleens of the treated animals con­
tain hapten-specific suppressor cells. Finally, the unresponsiveness 
elicited by hapten painted on UVB�exposed skin of UVB�S mice, 
and the tolerance produced by hapten application to cis-UCA­
injected skin (of both UVB-S and UVB-R mice) is not reversed by 
treating the animals with neutralizing anti-TNFa antibodies. 
Therefore, the induction of hapten-specific tolerance via UVB-ex­
posed skin is not dependent upon local TNFa in the same manner 
that CH induction is impaired in UVB-exposed skin. This realiza­
tion confirms the superstition that the tolerance that follows hapten 
application to UVB-exposed skin results from a different mecha­
nism than that which prevents UVB-S mice from developing CH 
under similar experimental conditions. At present we have no evi­
dence to implicate genetic factors in the tolerance induced by UVB 
radiation. The mere fact that UVB-induced tolerance occurs by a 
different pathogenic mechanism from UVB-impaired CH induc­
tion implies that different genetic factors may be operative. How­
ever, the finding that all mice (UVB-S and UVB-R) acquire sup­
pressor cells after UVB radiation might suggest that the genetic loci 
governing tolerance are not polymorphic. 
TOLERANCE INDUCTION IN HUMANS FOLLOWING 
HAPTEN APPLICATION TO UVB-IRRADIATED SKIN 
Tolerance is more difficult to study in humans than in mice. Because 
no reliable in vitro assays exist to detect hapten-specific tolerance 
with human blood cells, and because adoptive transfer studies can­
not be performed in human beings, detection of the tolerant state 
must rely on in vivo assays of the type first performed in mice. 
Accordingly, volunteers that were originally designated as UVB-S 
with the hapten DNCB were enrolled in a subsequent study in 
which a second, universally sensitizing, dose ofDNCB was applied 
to normal (unirradiated) buttock skin [26]. Thirty days later 
the forearms of these individuals were challenged with dilute 
DNCB to determine whether CH had been induced. As displayed 
in Fig 2. a small proportion of healthy UVB-S volunteers failed to 
develop CH when re-sensitization with DNCB was attempted. 
These individuals fulfill the functional criterion of "tolerance." 
Among UVB-S cancer patients, a much larger proportion (approxi­
mately 50%) failed to display CH when re-challenged. Subse­
quently, all of the normal and skin cancer volunteers that failed to 
respond to the second DNCB sensitization protocol were immu­
nized with a universally sensitizing dose of unrelated hapten, 
DPCP. With one exception, all developed intense CH [26]. The 
latter result confirms that the unresponsiveness ofDNCB detected 
in tJtese individuals is hapten-specific. In immunolo�ic terms, 
this "represents strong evidence for the existence of true toler­
ance. 
Therefore, as in mice, human beings can be rendered tolerant if a 
hapten is first encountered through skin that has been treated with 
acute, low-dose UVB radiation. However, in mice, all UVB-S 
strains have proved to be tolerant, whereas in human beings, only a 
subset of UVB-S individuals display the tolerance phenotype. Be­
cause of this dichotomy among UVB-S individuals, the possibility 
t Shimizu T, Arana M, Streielin JW: UVB, TNFa, and cis-Urocanic acid 
induce tolerance to hapten via a common, non-TNFa-dependent mecha­
nism (abstr).] Invest Dermato/100:565, 1993. 
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Pigure 2. Indac:d.on of tolerauce by hapten in UVB-S individuals. 
Groups of normal and skin cancer subjects previously designated as UVB-S 
received-2000 ag DNCB epicutaneously to untreated skin. The intensity of 
challenge reactions elicited on forearm skin 30 d later with DNCB (50 erg) 
are presented. 
exists that a different set of polymorphic genes may produce toler­
ance in humans compared to the genes responsible for impaired CH 
induction. The fact that the UVB-tolerance trait is highly enriched 
in skin-cancer patients underscores the possibility that the trait is 
genetically determined. 
SUMMARY AND CONCLUSIONS 
Sunlight-induced skin cancers are multifactorial diseases in which 
environmental and host genetic factors conspire to create the malig­
nant pathology. Ultraviolet B radiation appears to be the most im­
portant environmental factor in skin-cancer pathogenesis. In part, 
the role ofUVB radiation is to create mutations within the DNA of 
cutaneous cells. Some of these mutations lead inevitably to the 
emergence of malignantly transformed cells. Through time, these 
cells form clinical, and even life-threatening tumors. In this paper. 
another role for UVB radiation in the pathogenesis of skin cancer is 
considered, namely, the capacity of this form of solar energy to 
damage the cutaneous immune system and thereby to interfere with 
the host's ability to detect and destroy newly transformed cells. The 
cutaneous immune response to haptens, termed contact hypersensi­
tivity, is a model system that has been developed in both mice and 
humans to study the effect of UVB radiation on systemic and local 
immunity. It has been found that the ability of UVB radiation to 
damage the cutaneous immune system is genetically determined in 
mice. Circumstantial evidence suggests that this may also be the case 
in humans. If true, then susceptibility to sunlight-induced skin de­
pends not only on polymorphic gene loci that dictate type and 
degree of skin melariization. but on separate polymorphic loci that 
govern the cytokines and cells that mediate cutaneous immunity. 
Ultraviolet B radiation appears to have at least two distinct effects 
on the immune system of mice: it impairs the induction of CH, and 
it promotes tolerance to haptens first encountered via UVB-exposed 
skin. A similar situation probably exists in humans as well. There­
fore. the term UVB-induced immunosuppression embraces more 
than one phenomenon. It is anticipated that more than one regula­
tory pathway of the cutaneous immune system can be damaged by 
UVB radiation, and that each pathway is likely to be under separate 
genetic control. 
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